Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unfractionated Heparin Treatment”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Not applicableStudy completedNCT00541307
What this trial is testing

GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)

Who this might be right for
Peripheral Vascular Diseases
W.L.Gore & Associates 119
Not applicableUnknownNCT00669721
What this trial is testing

OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

Who this might be right for
Renal FailureHemodialysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Large-scale testing (Phase 3)Study completedNCT00182403
What this trial is testing

Fixed Dose Heparin Study

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
McMaster University 866
Large-scale testing (Phase 3)Study completedNCT00718354
What this trial is testing

Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT

Who this might be right for
Gastric CancerGastroesophageal Cancer
Thrombosis Research Institute 740
Large-scale testing (Phase 3)Study completedNCT00475098
What this trial is testing

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 553
Post-approval studies (Phase 4)Study completedNCT00806403
What this trial is testing

Comparison Between Thrombolysis and Primary Percutaneous Coronary Intervention (PCI) to Treat ST-Segment Elevation Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Sahlgrenska University Hospital 205
Not applicableUnknownNCT00510432
What this trial is testing

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

Who this might be right for
Allergy
Johann Wolfgang Goethe University Hospital 500
Post-approval studies (Phase 4)Study completedNCT00711308
What this trial is testing

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Who this might be right for
Acute Pulmonary Embolism
Complejo Hospitalario Xeral-Calde 102
Not applicableStudy completedNCT00358735
What this trial is testing

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Who this might be right for
Deep Vein Thrombosis of Lower LimbPulmonary Embolism (PE)Bleeding
Medical Compression Systems 411
Early research (Phase 1)Study completedNCT00622115
What this trial is testing

Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)

Who this might be right for
Thrombosis
Sanofi 72
Post-approval studies (Phase 4)Study completedNCT00277394
What this trial is testing

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Who this might be right for
Deep Vein Thrombosis
LEO Pharma 541
Post-approval studies (Phase 4)Study completedNCT01727453
What this trial is testing

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

Who this might be right for
Acute Gastrointestinal Bleeding
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40
Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Post-approval studies (Phase 4)Ended earlyNCT04397510
What this trial is testing

Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury

Who this might be right for
Covid-19ARDS, HumanAcute Lung Injury
Frederick Health 13
Not applicableUnknownNCT04462614
What this trial is testing

Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA

Who this might be right for
Chronic HemolysisVKAAnticoagulants / Administration & Dosage+7 more
CHU de Reims 49
Not applicableUnknownNCT04671160
What this trial is testing

Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.

Who this might be right for
Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
Medical University of Gdansk 80
Large-scale testing (Phase 3)Ended earlyNCT00484822
What this trial is testing

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)

Who this might be right for
Long-term Oral Anticoagulant Therapy
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 206
Testing effectiveness (Phase 2)WithdrawnNCT01263574
What this trial is testing

Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome

Who this might be right for
Catheter Related InfectionsShort Bowel Syndrome
Boston Children's Hospital
Post-approval studies (Phase 4)Study completedNCT00689520
What this trial is testing

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Hospital Universitari de Bellvitge 241
Early research (Phase 1)Study completedNCT05325346
What this trial is testing

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Who this might be right for
Heparin-induced Thrombocytopenia
Veralox Therapeutics 12
Next Page